Basma Adeem Medical company (TADAWUL:9626)
Saudi Arabia · Delayed Price · Currency is SAR 6.45
+0.39 (6.44%)
Sep 6, 2026, 2:52 PM AST
TADAWUL:9626 Balance Sheet
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 19.02 | 39.35 | 20.05 | 8.12 | 5.16 |
Cash & Short-Term Investments | 39.24 | 39.35 | 20.05 | 8.12 | 5.16 |
Cash Growth | 11.61% | 96.29% | 146.91% | 57.42% | - |
Accounts Receivable | - | - | - | - | 0.26 |
Other Receivables | 2.5 | 1.63 | 0.6 | 0.51 | 0.18 |
Receivables | 2.5 | 1.63 | 0.6 | 0.51 | 0.43 |
Inventory | 1.35 | 1.16 | 1.15 | 0.6 | 0.12 |
Prepaid Expenses | 0.71 | 0.48 | 0.37 | 0.36 | 0.09 |
Other Current Assets | 0.32 | 0.25 | 0.02 | 0.05 | 0.06 |
Total Current Assets | 44.12 | 42.87 | 22.19 | 9.64 | 5.86 |
Property, Plant & Equipment | 33.17 | 23.15 | 15.63 | 7.29 | 7.23 |
Other Intangible Assets | - | 0.21 | 0.07 | 0.04 | 0 |
Total Assets | 77.29 | 66.23 | 37.89 | 16.96 | 13.09 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 1.77 | 1.72 | 1.08 | 1.17 | 1.6 |
Accrued Expenses | 2.66 | 2.42 | 1.66 | 1.19 | 1.12 |
Current Portion of Leases | 1.97 | 1.41 | 1.03 | 0.95 | 0.23 |
Current Income Taxes Payable | 0.27 | 0.95 | 0.48 | 0.19 | 0.1 |
Other Current Liabilities | 0.16 | 0.06 | 0.01 | 0.04 | 0.04 |
Total Current Liabilities | 6.82 | 6.54 | 4.26 | 3.53 | 3.08 |
Long-Term Leases | 18.62 | 12.87 | 10.77 | 3.43 | 4.89 |
Pension & Post-Retirement Benefits | 0.99 | 0.74 | 0.55 | 0.2 | 0.17 |
Total Liabilities | 26.43 | 20.15 | 15.58 | 7.16 | 8.15 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 20 | 20 | 16 | 0.1 | 0.05 |
Additional Paid-In Capital | 14.13 | 14.13 | 1.6 | 1.14 | 1.19 |
Retained Earnings | 18.33 | 13.54 | 6.31 | 8.56 | 3.7 |
Treasury Stock | -1.6 | -1.6 | -1.6 | - | - |
Shareholders' Equity | 50.86 | 46.07 | 22.31 | 9.8 | 4.94 |
Total Liabilities & Equity | 77.29 | 66.23 | 37.89 | 16.96 | 13.09 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 20.59 | 14.28 | 11.79 | 4.37 | 5.12 |
Net Cash (Debt) | 18.65 | 25.07 | 8.25 | 3.75 | 0.04 |
Net Cash Growth | -18.95% | 203.72% | 120.28% | 9671.36% | - |
Net Cash Per Share | 1.01 | 1.39 | 0.71 | 0.39 | - |
Filing Date Shares Outstanding | 18.4 | 18.4 | 14.4 | 18.4 | - |
Total Common Shares Outstanding | 18.4 | 18.4 | 14.4 | - | - |
Working Capital | 37.3 | 36.32 | 17.92 | 6.1 | 2.78 |
Book Value Per Share | 2.76 | 2.50 | 1.55 | - | - |
Tangible Book Value | 50.86 | 45.86 | 22.24 | 9.77 | 4.94 |
Tangible Book Value Per Share | 2.76 | 2.49 | 1.54 | - | - |
Machinery | - | 6.95 | 3.58 | 3.42 | 2.79 |
Leasehold Improvements | - | 5.53 | 2 | 1.94 | 1.59 |